Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Software validation.

H Wenner1

  • 1EUROSPEC GmbH, Darmstadt, Germany.

Medical Device Technology
|March 8, 1997
PubMed
Summary

This article explains that risk management is crucial for medical device software development, aligning with EN 60601-1-4 standards. It compares US Food and Drug Administration regulations with European Medical Device Directive requirements for market compliance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Andrenogenital syndrome (author's transl)].

Deutsche medizinische Wochenschrift (1946)·1980
Same author

[Diagnosis and treatment of intraepithelial pavement cell epithelioma of the uterine cervix].

Memoires. Academie de chirurgie (France)·1952
See all related articles

Area of Science:

  • Medical device software development
  • Regulatory compliance in healthcare technology

Background:

  • EN 60601-1-4 mandates risk management for medical device software.
  • Navigating international regulations is complex for manufacturers.

Purpose of the Study:

  • To analyze EN 60601-1-4 risk management requirements.
  • To compare US FDA regulations with EU Medical Device Directive requirements.
  • To offer guidance for developing medical device software for US and EU markets.

Main Methods:

  • Comparative analysis of regulatory standards.
  • Examination of EN 60601-1-4 guidelines.
  • Review of FDA and EU directives.

Main Results:

  • Risk management is a core component of medical device software lifecycle.
  • Key differences and similarities exist between FDA and EU regulatory frameworks.
  • Compliance requires understanding both regional requirements.

Conclusions:

  • Adherence to EN 60601-1-4 is essential for safe medical device software.
  • Manufacturers must address specific FDA and EU regulations for market access.
  • Integrated risk management strategies facilitate global compliance.

Related Experiment Videos